Markt geschlossen -
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
1.45 USD | -2.03% | +3.57% | -17.61% |
Kurzporträt
Mitarbeiterzahl: 28
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Richard Miller
CEO | Chief Executive Officer | 73 | 27.01.14 |
Leiv Lea
DFI | Director of Finance/CFO | 70 | 27.01.14 |
James Rosenbaum
CTO | Chief Tech/Sci/R&D Officer | - | 21.07.22 |
Gabriel Luciano
CTO | Chief Tech/Sci/R&D Officer | - | 01.01.18 |
Chief Tech/Sci/R&D Officer | - | 01.01.19 | |
William Jones
PRN | Corporate Officer/Principal | 59 | - |
Jeffrey Arcara
PRN | Corporate Officer/Principal | - | 06.02. |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Richard Miller
CEO | Chief Executive Officer | 73 | 27.01.14 |
Ian Clark
BRD | Director/Board Member | 62 | 03.01.17 |
Terry Gould
BRD | Director/Board Member | 67 | 01.11.14 |
Peter Thompson
FOU | Founder | 64 | 27.01.14 |
Linda Grais
BRD | Director/Board Member | 68 | 28.01.19 |
Scott Morrison
BRD | Director/Board Member | 66 | 01.12.15 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 49 038 582 | 43 856 630 ( 89,43 %) | 0 | 89,43 % |
Unternehmenskontakt
Corvus Pharmaceuticals, Inc.
863 Mitten Road Suite 102
94010, Burlingame
+650 900 4520
http://www.corvuspharma.comSektor
Verlauf des Gewinns je Aktie
% 1. Jan. | Kap. | |
---|---|---|
-17.61% | 71.11 Mio. | |
+1.51% | 42.75 Mrd. | |
+8.57% | 41.34 Mrd. | |
+49.22% | 41.61 Mrd. | |
-12.36% | 26.59 Mrd. | |
+8.92% | 25.49 Mrd. | |
-25.13% | 18.12 Mrd. | |
+29.17% | 12.24 Mrd. | |
-3.12% | 11.76 Mrd. | |
+6.35% | 11 Mrd. |
- Börse
- Aktien
- A2AFXS Aktie
- Unternehmen Corvus Pharmaceuticals, Inc.